Pharmagene PLC To Set Up U.S. Base After IPO Raises $56 Mil.
U.K. drug discovery and development company Pharmagene plans to launch its informatics business in the U.S. following an initial public offering on the London Stock Exchange.
You may also be interested in...
The U.K. biotech company Pharmagene will use a private placement of $13.8 mil. (L8.6 mil.) to expand the company's Phase Zero target validation technologies and database products.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials